Voxelotor shortage status
2 active shortage notices across 2 countries.
Last updated 2 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Voxelotor
- Brand names
- Oxbryta
- Class
- Auto-created by Agenzia Italiana del Farmaco — Carenze scraper
Where Voxelotor is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| Greece | medium | 1 | 24 Sept 2024 | — | EOF |
| Italy | medium | 1 | 23 Sept 2024 | — | AIFA |
Why Voxelotor is in shortage
- causes not stated by the regulator — e.g. “Sospensione commercializzazione” (Italy)
Frequently asked questions
Is Voxelotor currently in shortage?
Yes. As of the latest regulator updates, Voxelotor has 2 active shortage notices across 2 countries (Greece, Italy). Status is refreshed daily from official regulatory sources.
Why is Voxelotor in shortage?
Regulators attribute the current Voxelotor shortages to causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Voxelotor shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Voxelotor status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.